Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 3
1950 1
1951 2
1952 5
1953 1
1954 3
1955 2
1956 9
1957 3
1958 15
1959 39
1960 63
1961 76
1962 98
1963 238
1964 450
1965 494
1966 551
1967 892
1968 1086
1969 1193
1970 1376
1971 1695
1972 1965
1973 2064
1974 2147
1975 1261
1976 635
1977 629
1978 492
1979 604
1980 550
1981 538
1982 523
1983 524
1984 616
1985 636
1986 633
1987 579
1988 737
1989 976
1990 1183
1991 1232
1992 1256
1993 1137
1994 1129
1995 1143
1996 1040
1997 986
1998 958
1999 860
2000 858
2001 780
2002 679
2003 615
2004 596
2005 571
2006 546
2007 596
2008 524
2009 453
2010 437
2011 383
2012 380
2013 360
2014 285
2015 294
2016 263
2017 244
2018 227
2019 192
2020 211
2021 158
2022 177
2023 122
2024 58

Text availability

Article attribute

Article type

Publication date

Search Results

44,620 results

Results by year

Filters applied: . Clear all
Page 1
Trifluridine-tipiracil plus bevacizumab versus trifluridine-tipiracil monotherapy for chemorefractory metastatic colorectal cancer: a systematic review and meta-analysis.
Aquino de Moraes FC, Dantas Leite Pessôa FD, Duarte de Castro Ribeiro CH, Rodrigues Fernandes M, Rodríguez Burbano RM, Carneiro Dos Santos NP. Aquino de Moraes FC, et al. BMC Cancer. 2024 Jun 3;24(1):674. doi: 10.1186/s12885-024-12447-8. BMC Cancer. 2024. PMID: 38825703 Free PMC article.
Endoplasmic reticulum transporter OAT2 regulates drug metabolism and interaction.
Arakawa H, Ishida N, Nakatsuji T, Matsumoto N, Imamura R, Shengyu D, Araya K, Horike SI, Tanaka-Yachi R, Kasahara M, Yoshioka T, Sumida Y, Ohmiya H, Daikoku T, Wakayama T, Nakamura K, Fujita KI, Kato Y. Arakawa H, et al. Biochem Pharmacol. 2024 Jul;225:116322. doi: 10.1016/j.bcp.2024.116322. Epub 2024 May 28. Biochem Pharmacol. 2024. PMID: 38815630 Free article.
Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.
Eholie SP, Ekouevi DK, Chazallon C, Charpentier C, Messou E, Diallo Z, Zoungrana J, Minga A, Ngom Gueye NF, Hawerlander D, Dembele F, Colin G, Tchounga B, Karcher S, Le Carrou J, Tchabert-Guié A, Toni TD, Ouédraogo AS, Bado G, Toure Kane C, Seydi M, Poda A, Mensah E, Diallo I, Drabo YJ, Anglaret X, Brun-Vezinet F; FIT-2 study group. Eholie SP, et al. Lancet HIV. 2024 Jun;11(6):e380-e388. doi: 10.1016/S2352-3018(24)00085-7. Epub 2024 May 10. Lancet HIV. 2024. PMID: 38740027 Free article. Clinical Trial.
44,620 results
You have reached the last available page of results. Please see the User Guide for more information.
-